Neurological Disease Mechanisms and Treatments
Neurological Disease Mechanisms and Treatments is a research topic within Neurology. Science Explorer counts 31k research works in it since 1950. 14.7% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on chronic cerebral hypoperfusion and its association with neurodegenerative diseases, vascular cognitive impairment, white matter lesions, and oxidative stress. The research includes experimental models, glial activation, memory impairment, and the neuroprotective effects of various compounds.
- Cerebral Hypoperfusion
- Vascular Cognitive Impairment
- White Matter Lesions
- Neurodegenerative Diseases
- Experimental Models
- Oxidative Stress
- Glial Activation
- Memory Impairment
- Animal Models
- Neuroprotective Effects
- Research works
- 31k fractional, since 1950
- In the world top 10%
- 4.6k per year above
- Top-10% rate
- 14.7% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -3% the tick is no change
Which countries lead Neurological Disease Mechanisms and Treatments research?
By volume, China and the United States publish the most (2.3k and 866 works in 2022–2025).
By volume, 2022–2025
- 1 China 2.3k works
- 2 United States 866 works
- 3 India 214 works
- 4 Russia 184 works
- 5 Japan 181 works
- 6 South Korea 162 works
- 7 United Kingdom 121 works
- 8 Iran 105 works
- 9 Indonesia 87 works
- 10 Germany 81 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Neurological Disease Mechanisms and Treatments research?
By volume in 2022–2025, Capital Medical University publishes the most Neurological Disease Mechanisms and Treatments research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Beijing University of Chinese Medicine.
By volume, 2022–2025
- 1 Capital Medical UniversityChina 42 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 42 works
- 3 Beijing University of Chinese MedicineChina 26 works
- 4 Zhejiang Chinese Medical UniversityChina 24 works
- 5 Nanjing University of Chinese MedicineChina 24 works
- 6 Shaanxi University of Chinese MedicineChina 22 works
- 7 Chengdu University of Traditional Chinese MedicineChina 22 works
- 8 Nanjing Medical UniversityChina 19 works
- 9 Anhui University of Traditional Chinese MedicineChina 18 works
- 10 Guangzhou University of Chinese MedicineChina 17 works
Who are the leading researchers in Neurological Disease Mechanisms and Treatments?
The most-cited researchers publishing on Neurological Disease Mechanisms and Treatments include Gelin Xu, Narayanaswamy Venketasubramanian and John C. Morris.
- 1 Gelin Xu China 6.1k citations
- 2 Narayanaswamy Venketasubramanian Singapore 5.4k citations
- 3 John C. Morris United States 5.1k citations
- 4 John Hardy United Kingdom 4k citations
- 5 Ronald C. Petersen United States 4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Neurological Disease Mechanisms and Treatments research done?
The largest centres of Neurological Disease Mechanisms and Treatments research in 2022–2025 are Beijing (China), Shanghai (China), Nanjing (China) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Xianyang and Shijiazhuang.
Largest cities, 2022–2025
Where it is the local speciality
- XianyangCN · 31.9 works27×
- ShijiazhuangCN · 46.0 works8.5×
Location quotient: how much more of its research is in Neurological Disease Mechanisms and Treatments than the world average.
Where is the best place to study Neurological Disease Mechanisms and Treatments?
Among universities, judged by research, Zhejiang Chinese Medical University, Capital Medical University and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Zhejiang Chinese Medical UniversityChina | 58.6 | 35.2% | 18.4× | 24 | -55.7% |
| 2 | Capital Medical UniversityChina | 58.5 | 17.2% | 14.0× | 42 | -22.6% |
| 3 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 56.8 | 21.7% | 8.3× | 42 | -16.2% |
| 4 | Mashhad University of Medical SciencesIran | 56.4 | 40.8% | 6.6× | 8 | +253.4% |
| 5 | Chengdu University of Traditional Chinese MedicineChina | 55.3 | 31.6% | 19.2× | 22 | -61.5% |
| 6 | The University of Texas Health Science Center at HoustonUnited States | 54.9 | 4.6% | 10.9× | 17 | +255.4% |
| 7 | Nanjing University of Chinese MedicineChina | 54.6 | 28.1% | 18.3× | 24 | -57.9% |
| 8 | Beijing University of Chinese MedicineChina | 54.0 | 21.8% | 29.2× | 26 | -25.0% |
| 9 | Guangzhou University of Chinese MedicineChina | 52.2 | 29.3% | 17.6× | 17 | -44.3% |
| 10 | Anhui University of Traditional Chinese MedicineChina | 51.4 | 29.3% | 36.8× | 18 | -53.1% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Neurological Disease Mechanisms and Treatments research growing?
Output in 2018–2022 was 3% lower than in 2013–2017, peaking in 2013. The fastest-growing topics are Neurological Disease Mechanisms and Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.